The opioid epidemic, obesity, federal employee suicide and depression rates, and drug prices are on our readers’ minds.

Eli Lilly acquires SiteOne Therapeutics for up to $1B, signaling potential uptick in Big Pharma deals and focus on non-opioid ...

Eli Lilly will buy privately held SiteOne Therapeutics in a deal worth as much as $1 billion, the companies said on Tuesday, ...

As large sums of money from opioid settlements trickle into Ohio communities, some are choosing to fund law enforcement ...

Indiana Governor Braun signed a law easing restrictions on opioid prescriptions for chronic pain patients with implantable ...

Harlan County, Kentucky, had a drug overdose rate two times the national average. Through funding and community programs, ...

The acquisition expands Lilly’s pain pipeline with a slate of drugs targeting ion channel proteins like NaV1.7 and NaV1.8.

Congress must commit to a smarter approach to combat opioid addiction, empowering local communities and insisting on ...

Stemming the tide of opioid addiction in Central Illinois takes that person-to-person connection, a realization that ...

The legislation, originally the idea of an Elgin high school student, is aimed at reducing the number of opioid-related ...

A recent study conducted across nine Iowa hospitals has shown promising results in reducing postoperative opioid ...

Special Agent Kimble told KHOU 11 News that Nitazene is a synthetic opioid more than 25 times more potent than fentanyl.